-
05:53:37 PM

ELAN Stock News

12/09/22 10:48 AM
NYSE : ELAN
fda approval
Elanco Announces FDA Approval of Bexacat™ (bexagliflozin tablets) – the First-of-its-Kind Oral Feline Diabetes Treatment Option
Today Elanco Animal Health announced the U.S. Food and Drug Administration approved Bexacat™, the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus, expanding Elanco’ s innovative feline portfolio while addressing an unmet need for this chronic condition in adult cats. An estimated 600,000 cats...
RHEA-AI
neutral
08/16/22 8:00 AM
NYSE : ELAN
Elanco Releases 2021 Environmental, Social and Governance Report Highlighting Progress on Healthy Purpose™ Goals
Elanco Animal Health Incorporated today released its 2021 Environmental, Social and Governance Report“ Changing The World One Animal at a Time” highlighting the company’ s progress on relevant ESG topics and metrics. The 2021 report outlines the company’ s approach to sustainability, called Elanco’ s Healthy Purpose™, and goals– which align with the United...
RHEA-AI
very positive
07/18/22 6:30 AM
NYSE : ELAN
earnings
Elanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results Announcement
Elanco Animal Health Incorporated will announce its second quarter 2022 financial results on Monday, August 8, 2022. Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians,...
RHEA-AI
neutral